New insights into cell cycle regulation and DNA damage response in embryonic stem cells

International Review of Cell and Molecular Biology

Volumn 299, Issue , 2012, Pages 161-198

  Suvorova, Irina I ^a,b   Katolikova, Natalia V ^a   Pospelov, Valery A ^a,b  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

ATM ATR; Cell cycle checkpoints; DNA damage response; Embryonic stem cells; Gamma H2AX foci; P21Waf1; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE H2AX; PROTEIN P53; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL STRUCTURE; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA END JOINING REPAIR; EMBRYONIC STEM CELL; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC CELL;

EID: 84865963772     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394310-1.00004-7     Document Type: Chapter

References (134)

1. Adams B.R., Golding S.E., Rao R.R., Valerie K. Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS One 2010, 5(4):e10001.
2. Adams B.R., Hawkins A.J., Povirk L.F., Valerie K. ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging (Albany NY) 2010, 2(9):582-596.
3. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 1998, 8:145-155.
4. Ardehalia R., Inlaya M.A., Alia S.R., Tanga C., Drukkera M., Weissman I.L. Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors. Proc. Natl Acad. Sci. USA 2011, 108(8):3282-3287.
5. Bai H., Chen K., Gao Y.-X., Arzigian M., Xie Y.-L., Malcosky C., Yang Y.-G., Wen-Shu Wu W.-S., Wang Z.Z. Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Res. 2012, 8:26-37.
6. Banath J.P., Banuelos C.A., Klokov D., MacPhail S.M., Lansdorp P.M., Olive P.L. Explanation for excessive DNA single-strand breaks and endogenous repair foci in pluripotent mouse embryonic stem cells. Exp. Cell Res. 2009, 315(8):1505-1520.
7. Banito A., Rashid S.T., Acosta J.C., Li S.D., Pereira C.F., Geti I., Pinho S., Silva J.C., Azuara V., Walsh M., Vallier L., Gil J. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23:2134-2139.
8. Banuelos C.A., Banath J.P., MacPhail S.H., Zhao J., Eaves C.A., O'Connor M.D., Lansdorp P.M., Olive P.L. Mouse but not human embryonic stem cells are deficient in rejoining of ionizing radiation-induced DNA double-strand breaks. DNA Repair (Amst.) 2008, 7:1471-1483.
9. Barta T., Vinarsky V., Holubcova Z., Dolezalova D., Verner J., Pospisilova S., Dvorak P., Hampl A. Human embryonic stem cells are capable of executing G1/S checkpoint activation. Stem Cells 2010, 28:1143-1152.
10. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.-V., Kolettas E., Niforou K., Zoumpourlis V.C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C.L., Dyrskjot L., Ørntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T.D., Bartek J., Gorgoulis V.G. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
11. Becker K.A., Ghule P.N., Therrien J.A., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J. Cell. Physiol. 2006, 209:883-893.
12. Becker K.A., Stein J.L., Lian J.B., van Wijnen A.J., Stein G.S. Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming. J. Cell. Physiol. 2010, 222(1):103-110.
13. Bedelbaeva K., Snydera A., Gourevitch D., Clarka L., Zhanga X.-V., Leferovich J., Cheverud J.M., Lieberman P., Heber-Katz E. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc. Natl Acad. Sci. USA 2010, 107(13):5845-5850.
14. Betts D.H., Kalionis B. Viable iPSC mice: a step closer to therapeutic applications in humans?. Mol. Hum. Reprod. 2010, 16(2):57-62.
15. Bhave V.S., Paranjpe S., Bowen W.C., Donthamsetty S., Bell A.W., Khillan J.S., Michalopoulos G.K. Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo. Hepatology 2011, 54:1360-1370.
16. Bogomazova A.N., Lagarkova M.A., Tskhovrebova L.V., Shutova M.V., Kiselev S.L. Error-prone nonhomologous end joining repair operates in human pluripotent stem cells during late G2. Aging (Albany NY) 2011, 3:584-596.
17. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122(6):947-956.
18. Burdon T., Smith A., Savatier P. Signalling, cell cycle and pluripotence in embryonic stem cells. Trends Cell Biol. 2002, 12:432-438.
19. Chen T., Shen L., Yu J., Wan H., Guo A., Chen J., Long Y., Zhao J., Pei G. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 2011, 10:908-911.
20. Chung J.H., Bunz F. Cdk2 is required for p53-independent G2/M checkpoint control. PLoS Genet. 2010, 6(2):e1000863.
21. Chuykin I.A., Lianguzova M.S., Pospelova T.V., Pospelov V.A. Activation of DNA damage response signaling in mouse embryonic stem cells. Cell Cycle 2008, 7:2922-2928.
22. Conesa C., Doss M.X., Antzelevitch C., Sachinidis A., Sancho J., Carrodeguas J.A. Identification of specific pluripotent stem cell death-inducing small molecules by chemical screening. Stem Cell Rev. 2012, 8(1):116-127.
23. Conklin J.F., Sage J. Keeping an eye on retinoblastoma control of human embryonic stem cells. J. Cell. Biochem. 2009, 108:1023-1030.
24. Corbet S.W., Clarke A.R., Gledhill S., Wyllie A.H. P53-dependent and independent links between DNA-damage, apoptosis and mutation frequency in ES cells. Oncogene 1999, 18:1537-1544.
25. Dannenberg J.H., van Rossum A., Schuijff L., te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 2000, 14:3051-3064.
26. Demidenko Z.N., Zubova S.G., Bukreeva E.I., Pospelov V.A., Pospelova T.V., Blagosklonny M.V. Rapamycin decelerates cellular senescence. Cell Cycle 2009, 8(12):1888-1895.
27. de Klein A., Muijtjens M., van Os R., Verhoeven Y., Smit B., Carr A.M., Lehmann A.R., Hoeijmakers J.H. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 2000, 10(8):479-482.
28. de Vries A., Flores E.R., Miranda B., Hsieh H.M., van Oostrom C.T., Sage J., Jacks T. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc. Natl Acad. Sci. USA 2002, 99(5):2948-2953.
29. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre' M., Nuciforo P.G., Bensimon A., Maestro R., Pelicci P.G., d'Adda di Fagagna F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
30. Di Micco R., Sulli G., Dobreva M., Liontos M., Botrugno O.A., Gargiulo G. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat. Cell Biol. 2011, 13:292-302.
31. Efeyan A., Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007, 6:1006-1010.
32. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl Acad. Sci. USA 1996, 93(23):13084-13089.
33. Erster S., Moll U.M. Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo. Cell Cycle 2004, 3(12):1492-1495.
34. Faast R., White J., Cartwright P., Crocker L., Sarcevic B., Dalton S. Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16(INK4a). Oncogene 2004, 23:491-502.
35. Fan J., Robert C., Jang Y.Y., Liu H., Sharkis S., Baylin S.B., Rassool F.V. Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining. Mutat. Res. 2011, 713:8-17.
36. Fasano C.A., Dimos J.T., Ivanova N.B., et al. shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 2007, 1:87-99.
37. Filipczyk A.A., Laslett A.L., Mummery C., Pera M.F. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res. 2007, 1:45-60.
38. Fluckiger A.C., Marcy G., Marchand M., N'egre D., Cosset F.L., Mitalipov S., Wolf D., Savatier P., Dehay C. Cell cycle features of primate embryonic stem cells. Stem Cells 2006, 24:547-556.
39. Folmes C.D.L., Nelson T.J., Martinez-Fernandez A., Arrell D.K., Lindor J.Z., Dzeja P.P., Ikeda Y., Perez-Terzic C., Terzic T. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011, 14:264-271.
40. Fragkos M., Jurvansuu J., Beard P. H2AX is required for cell cycle arrest via the p53/p21 pathway. Mol. Cell Biol. 2009, 29(10):2828-2840.
41. Gore A., Li Z., Fung H.-L., Young J.E., Agarwal S., Antosiewicz-Bourget J., Canto I., Giorgetti A., Israel M.A., Kiskinis E., Lee J.-H., Loh Y.-H., Manos P.D., Montserrat N., Panopoulos A.D., Ruiz S., Wilbert M.L., Yu J., Kirkness E.F., Belmonte J.I.B., Rossi D.J., Thomson J.A., Eggan K., Daley G.Q., Goldstein L.S.B., Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
42. Grandela C., Pera M.F., Grimmond S.M., Kolle G., Wolvetang E.J. p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Stem Cell Res. 2007, 1:116-128.
43. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462(7273):595-601.
44. Hanna J., Cheng A.W., Saha K., Kim J., Lengner C.J., Soldner F., Cassady J.P., Muffat J., Carey B.W., Jaenisch R. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 2010, 107:9222-9227.
45. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460(7259):1132-1135.
46. Hong Y., Stambrook P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl Acad. Sci. USA 2004, 101:14443-14448.
47. Hong Y., Cervantes R.B., Tichy E., Tischfield J.A., Stambrook P.J. Protecting genomic integrity in somatic cells and embryonic stem cells. Mutat. Res. 2007, 614:48-55.
48. Hu H., Gatti R.A. MicroRNAs: new players in the DNA damage response. J. Mol. Cell Biol. 2011, 3:151-158.
49. Hunt C.R., Pandita R.K., Laszlo A., Higashikubo R., Agarwal M., Kitamura T., Gupta A., Rief N., Horikoshi N., Baskaran R., Lee J.H., Löbrich M., Paull T.T., Roti Roti J.L., Pandita T.K. Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res. 2007, 67:3010-3017.
50. Ikura T., Satoshi T., Akemi K., Hiroki S., Naduparambil J., Ravindra A., Kristine Y., Shunsuke I., Isao K., Kiyoji T., Hiroshi K., Masae I., Shuichi N., Takashi I., Akihiko M., Kiyoshi M., Shunichi T., Richard F., Kazuhiko I., Kenji K. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol. Cell Biol. 2007, 27:7028-7040.
51. Jain A.K., Allton K., Iacovino M., Mahen E., Milczarek R.J., Thomas P., Zwaka T.P., Kyba M., Barton M.B. p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol. 2012, 10(2):e1001268.
52. Jones S.M., Kazlauskas A. Growth-factor-dependent mitogenesis requires two distinct phases of signaling. Nat. Cell Biol. 2001, 3:165-172.
53. Kallas A., Pook M., Maimets M., Zimmermann K., Maimets T. Nocodazole treatment decreases expression of pluripotency markers Nanog and Oct4 in human embryonic stem cells. PLoS One 2011, 6(4):e19114.
54. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., Wahl J.M., Belmonte J.C. Linking the p53 tumor suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1145.
55. Kim J.M., Nakao K., Nakamura K., Saito I., Katsuki M., Arai K.-i., Masai H. Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death. EMBO J. 2002, 21(9):2168-2179.
56. Koledova Z., Kafkova L.R., Calabkova L., Krystof V., Dolezel P., Divoky V. Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells. Stem Cells Dev. 2010, 1:181-194.
57. Koledova Z., Kafkova L.R., Kramer A., Divoky V. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells. Stem Cells 2010, 28:450-461.
58. Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A., Aït-Hamou N., Leschik J., Pellestor F., Ramirez J.M., De Vos J., Lehmann S., Lemaitre J.M. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011, 25(21):2248-2253.
59. Lee J., Go Y., Kang I., Han Y.M., Kim J. Oct4 controls cell-cycle progression of embryonic stem cells. Biochem. J. 2010, 426:171-181.
60. Lee K.H., Li M., Michalowski A.M., Zhang X., Liao H., Chen L., Xu Y., Wu X., Huang J. A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc. Natl Acad. Sci. USA 2010, 107:69-74.
61. Li H., Collado M., Villasante A., Strati K., Ortega S., Canamero M., Blasco M.A., Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1140.
62. Li M., Huang J. A puzzling role of p53 in mouse embryonic stem cells. Cell Cycle 2010, 9(9):1669-1670.
63. Li Y., Zhang Q., Yin X., Weifeng Yang W., Du Y., Hou P., Ge J., Liu C., Zhang W., Zhang X., Yetao Wu Y., Li H., Liu K., Wu C., Song Z., Zhao Y., Shi Y., Deng H. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 2011, 21:196-204.
64. Lichner Z., Páll E., Kerekes A., Pállinger E., Maraghechi P., Bosze Z., Gócza E. The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells. Differentiation 2011, 81(1):11-24.
65. Ligon K.L., Huillard E., Mehta S., et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 2007, 53:503-517.
66. Lin T., Chao C., Saito S., Mazur S.J., Murphy M.E., Appella E., Xu Y. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 2005, 7:165-171.
67. Lukas J., Lukas C., Bartek J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time DNA. Repair 2004, 3(8-9):997-1007.
68. Madden D.T., Davila-Kruger D., Melov S., Bredesen D.E. Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members. PLoS One 2011, 6(12):e28530.
69. Maimets T., Neganova I., Armstrong L., Lako M. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008, 27:5277-5287.
70. Malashicheva A.B., Kislyakova T.V., Aksenov N.D., Osipov K.A., Pospelov V.A. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Oncogene 2000, 19:3858-3865.
71. Malashicheva A.B., Kisliakova T.V., Savatier P., Pospelov V.A. Embryonal stem cells do not undergo cell cycle arrest upon exposure to damaging factors. Tsitologiia (Rus.) 2002, 44:643-648.
72. Mallannaa A.K., Rizzino A. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev. Biol. 2010, 344(1):16-25.
73. Mandal P.K., Blanpain C., Rossi D.J. DNA damage response in adult stem cells: pathways and consequences. Nat. Rev. Mol. Cell Biol. 2011, 12:199-202.
74. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., Blasco M.A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1155.
75. Maynard S., Swistowska A.M., Lee J.W., Liu Y., Liu S.T., Da Cruz A.B., Rao M., de Souza-Pinto N.C., Zeng X., Bohr V.A. Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells 2008, 26:2266-2274.
76. McManus K.J., Hendzel M.J. ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol. Biol. Cell 2005, 16:5013-5025.
77. Menendez J.A., Vellon L., Oliveras-Ferraros C., Cufí, S., Vazquez-Martin A. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011, 10(21):3658-3677.
78. Menendez S., Camus S., Herreria A., Paramonov I., Morera L.B., Collado M., Pekarik V., Maceda I., Edel M., Consiglio A., Sanchez A., Li H., Serrano M., Belmonte J.C.I. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Aging Cell 2012, 11:41-50.
79. Momcilovic O., Choi S., Varum S., Bakkenist C., Schatten G., Navara C. Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells. Stem Cells 2009, 27:1822-1835.
80. Momcilovic O., Knobloch L., Fornsaglio J., Varum S., Easley C., Schatten G. DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One 2010, 5(10):e13410.
81. Momcilovic O., Navara C., Schatten G. Cell cycle adaptations and maintenance of genomic integrity in embryonic stem cells and induced pluripotent stem cells. Results Probl. Cell Differ. 2011, 53:415-458.
82. Murga M., Bunting S., Montana M.F., Soria R., Mulero F., Canamero M., Lee Y., McKinnon P.J., Nussenzweig A., Fernandez-Capetillo O. A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat. Genet. 2009, 41:891-899.
83. Myers J.S., Cortez D. Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J. Biol. Chem. 2006, 281:9346-9350.
84. Neganova I., Zhang X., Atkinson S., Lako M. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009, 28:20-30.
85. Neganova I., Vilella F., Atkinson S.P., Lloret M., Passos J.F., von Zglinicki T., O'Connor J.E., Burks D., Jones R., Armstrong L., Lako M. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011, 29:651-659.
86. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000, 102(6):849-862.
87. Ohgushi M., Matsumura M., Eiraku M., Murakami K., Aramaki T., Nishiyama A., Muguruma K., Nakano T., Suga H., Ueno M., Ishizaki T., Suemori H., Narumiya S., Niwa H., Sasai Y. Molecular pathway and cell state responsible or dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 2010, 7:225-239.
88. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
89. Okoshi R., Ozaki T., Yamamoto H., Ando K., Koida N., Ono S., Koda T., Kamijo T., Nakagawara A., Kizaki H. Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J. Biol. Chem. 2008, 283(7):3979-3987.
90. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
91. Perucca P., Cazzalini O., Madine M., Savio M., Laskey R.A., Vannini V., Prosperi E., Stivala L.A. Loss of p21 CDKN1A impairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescence. Cell Cycle 2009, 8(1):105-114.
92. Pospelova T.V., Demidenko Z.N., Bukreeva E.I., Pospelov V.A., Gudkov A.V., Blagosklonny M.V. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009, 8:4112-4118.
93. Prigione A., Adajaye J. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int. J. Dev. Biol. 2010, 54:1729-1741.
94. Prigione A., Fauler B., Lurz R., Lehrach H., Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28:721-733.
95. Prigione A., Hossini A., Lichtner B., Serin A., Fauler B., Megges M., Lurz R., Lehrach H., Makrantonaki E., Christos C., Zouboulis C.C., Adjaye J. Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One 2011, 6(11):e27352.
96. Qin H., Yu T., Qing T., Liu Y., Zhao Y., Cai J., Li J., Song Z., Qu X., Zhou P., Wu J., Ding M., Deng H. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J. Biol. Chem. 2007, 282:5842-5852.
97. Roque T., Haton C., Etienne O., Chicheportiche A., Rousseau L., Maertin L., Mouthon M.A., Boussin F.D. Lack of a p21waf1/Cip-dependent G1/S checkpoint in neural stem and progenitor cells after DNA damage in vivo. Stem Cells 2012, 30:537-547.
98. Rossi D.J., Seita J., Czechowicz A., Bhattacharya D., Bryder D., Weissman I.L. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 2007, 6(19):2371-2376.
99. Sabapathy K., Klemm M., Jaenisch R., Wagner E.F. Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 1997, 16:6217-6229.
100. Saretzki G., Armstrong L., Leake A., Lako M., von Zglinicki T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 2004, 22(6):962-971.
101. Saretzki G., Walter T., Atkinson S., Passos J.F., Bareth B., Keith W.N., Stewart R., Hoare S., Stojkovic M., Armstrong L., von Zglinicki T., Lako M. Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 2008, 26(2):455-464.
102. Sarig R., Rivlin N., Brosh R., Bornstein C., Kamer I., Ezra O., Molchadsky A., Ynger N.G., Brenner O., Rotter V. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J. Exp. Med. 2010, 9:2127-2140.
103. Sato N., Meijer L., Skaltsounis L., Greengard P., Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10:55-63.
104. Sawa M., Masai H. Drug design with Cdc7 kinase: a potential novel cancer therapy target. Drug Design Dev. Ther. 2008, 2:255-264.
105. Schneider L., Fumagalli M., d'Adda di Fagagna F. Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency. Cell Death Differ. 2012, 19:582-591.
106. Schratt G., Weinhold B., Lundberg A.S., Schuck S., Berger J., Schwarz H., Weinberg R.A., Ruther U., Nordheim A. Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol. Cell Biol. 2001, 21:2933-2943.
107. Serrano L., Liang L., Chang Y., Deng L., Maulion C., Nguyen S., Tischfield J.A. Homologous recombination conserves DNA sequence integrity throughout the cell cycle in embryonic stem cells. Stem Cells Dev. 2011, 20:363-374.
108. Sherman M.H., Bassing C.H., Teitell M.A. Regulation of cell differentiation by the DNA damage response. Trends Cell Biol. 2011, 21(5):312-319.
109. Silva J., Barrandon O., Nichols J., Kawaguchi J., Theunissen T.W., Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008, 6(10):253.
110. Sineva G.S., Pospelov V.A. Inhibition of GSK3beta enhances both adhesive and signaling activities of beta-catenin in mouse embryonic stem cells. Biol. Cell 2010, 102:549-560.
111. Sokolov M.V., Panyutin I.V., Panyutin I.G., Neumann R.D. Dynamics of the transcriptome response of cultured human embryonic stem cells to ionizing radiation exposure. Mutat. Res. 2011, 709-710:40-48.
112. Solozobova V., Rolletschek A., Blattner C. Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol. 2009, 10:46.
113. Solozobova V., Blattner C. Regulation of p53 in embryonic stem cells. Exp. Cell Res. 2010, 316:2434-2446.
114. Solozobova V., Blattner C. p53 in stem cells. World J. Biol. Chem. 2011, 2:202-214.
115. Song H., Chung S.K., Xu Y. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 2010, 6:80-89.
116. Sørensen C.S., Syljuasen R.G. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res. 2012, 40(2):2477-2486.
117. Soutoglou E., Misteli T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 2008, 320:1507-1510.
118. Spike B.T., Wahl G.M. P53, stem cells, and reprogramming: tumor suppression beyond guarding the genome. Genes Cancer 2011, 2(4):404-419.
119. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010, 24:2239-2263.
120. Stead E., White J., Faast R., Conn S., Goldstone S., Rathjen J., Dhingra U., Rathjen P., Walker D., Dalton S. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 2002, 21:8320-8333.
121. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
122. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
123. Tichy E.D., Stambrook P.J. DNA repair in murine embryonic stem cells and differentiated cells. Exp. Cell Res. 2008, 314:1929-1936.
124. Tichy E.D., Pillai R., Deng L., Liang L., Tischfield J., Schwemberger S.J., Babcock G.F., Stambrook P.J. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev. 2010, 11:1699-1711.
125. Tominaga Y., Li C., Wang R.H., Deng C.X. Murine Wee1 plays a critical role in cell cycle regulation and pre-implantation stages of embryonic development. Int. J. Biol. Sci. 2006, 2:161-170.
126. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl Acad. Sci. USA 1996, 93:6236-6240.
127. Utika J., Polo J.M., Stadtfeld M., Maherali N., Kulalert W., Walsh R., Khalil A., Rheinwald J.G., Hochedlinger K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009, 460:1145-1149.
128. Valerie K., Povirk L.F. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 2003, 22:5792-5812.
129. Varum S., Rodrigues A.S., Moura M.B., Momcilovic O., Easley C.A., et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 2011, 6(6):e20914.
130. Wang Y., Baskerville S., Shenoy A., Babiarz J.E., Baehner L., Blelloch R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat. Genet. 2008, 40(12):1478-1483.
131. White J., Stead E., Faast R., Conn S., Cartwright P., Dalton S. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol. Biol. Cell 2005, 16:2018-2027.
132. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A. The ground state of embryonic stem cell self-renewal. Nature 2008, 453(7194):519-523.
133. Zhang X., Neganova I., Przyborski S., Yang C., Cooke M., Atkinson S.P., Anyfantis G., Fenyk S., Keith W.N., Hoare S.F., Hughes O., Strachan T., Stojkovic M., Hinds P.W., Armstrong L., Lako M. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J. Cell. Biol. 2009, 184:67-82.
134. Zhao T., Xu Y. p53 and stem cells: new developments and new concerns. Trends Cell Biol. 2010, 20(3):170-175.